메뉴 건너뛰기
Critical Care Medicine
Volumn 36, Issue 9, 2008, Pages 2694-2695
Selective COX-2 inhibitors: New insights into mechanisms of side effects?
Author keywords

Cardiovascular function; COX 2 inhibitors; Experimental; Myocardial ischemiareperfusion injury; Rofecoxib
Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; PROSTACYCLIN; ROFECOXIB; TERUTROBAN; THROMBOXANE A2; 3 ((6 AMINO (4 CHLOROBENZENESULFONYL) 2 METHYL 5,6,7,8 TETRAHYDRONAPHT) 1 YL)PROPIONIC ACID; 3-((6-AMINO-(4-CHLOROBENZENESULFONYL)-2-METHYL-5,6,7,8-TETRAHYDRONAPHT)-1-YL)PROPIONIC ACID; LACTONE; NAPHTHALENE DERIVATIVE; PROPIONIC ACID DERIVATIVE; SULFONE; THROMBOXANE RECEPTOR;
EID: 53049107141     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181843d69     Document Type: Editorial
Times cited : (3)
References (10)
  • 1
    • 0034707105 scopus 로고    scopus 로고
    • Bombardier C, Laine L, Reicin A, et al: Comparison of upper gastrointestinal toxicity of ro-fecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343:1520-1528, 2 p following 1528
    • Bombardier C, Laine L, Reicin A, et al: Comparison of upper gastrointestinal toxicity of ro-fecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343:1520-1528, 2 p following 1528
  • 2
    • 19744380776 scopus 로고    scopus 로고
    • Cardiovascular events associated with rofe-coxib in a colorectal adenoma chemopreven-tion trial
    • Bresalier RS, Sandler RS, Quan H, et al: Cardiovascular events associated with rofe-coxib in a colorectal adenoma chemopreven-tion trial. N Engl J Med 2005; 352:1092-1102
    • (2005) N Engl J Med , vol.352 , pp. 1092-1102
    • Bresalier, R.S.1    Sandler, R.S.2    Quan, H.3
  • 3
    • 20144365496 scopus 로고    scopus 로고
    • Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention 2
    • Solomon SD, McMurray JJ, Pfeffer MA, et al: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention 2. N Engl J Med 2005; 352: 1071-1080
    • (2005) N Engl J Med , vol.352 , pp. 1071-1080
    • Solomon, S.D.1    McMurray, J.J.2    Pfeffer, M.A.3
  • 4
    • 33744976771 scopus 로고    scopus 로고
    • Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
    • Kearney PM, Baigent C, Godwin J, et al: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332:1302-1308
    • (2006) BMJ , vol.332 , pp. 1302-1308
    • Kearney, P.M.1    Baigent, C.2    Godwin, J.3
  • 5
    • 33749339372 scopus 로고    scopus 로고
    • Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 1
    • McGettigan P, Henry D: Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 1. JAMA 2006; 296:1633-1644
    • (2006) JAMA , vol.296 , pp. 1633-1644
    • McGettigan, P.1    Henry, D.2
  • 6
    • 0021269059 scopus 로고
    • Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation 3
    • FitzGerald GA, Smith B, Pedersen AK, et al: Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation 3. N Engl J Med 1984; 310: 1065-1068
    • (1984) N Engl J Med , vol.310 , pp. 1065-1068
    • FitzGerald, G.A.1    Smith, B.2    Pedersen, A.K.3
  • 7
    • 0028228508 scopus 로고
    • cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla 1
    • Namba T, Oida H, Sugimoto Y, et al: cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla 1. J Biol Chem 1994; 269:9986-9992
    • (1994) J Biol Chem , vol.269 , pp. 9986-9992
    • Namba, T.1    Oida, H.2    Sugimoto, Y.3
  • 8
    • 0026072992 scopus 로고
    • Cloning and expression of cDNA for a human thromboxane A2 receptor 1
    • Hirata M, Hayashi Y, Ushikubi F, et al: Cloning and expression of cDNA for a human thromboxane A2 receptor 1. Nature 1991; 349:617-620
    • (1991) Nature , vol.349 , pp. 617-620
    • Hirata, M.1    Hayashi, Y.2    Ushikubi, F.3
  • 9
    • 0037134011 scopus 로고    scopus 로고
    • Role of prostacyclin in the cardiovascular response to thromboxane A2 3
    • Cheng Y, Austin SC, Rocca B, et al: Role of prostacyclin in the cardiovascular response to thromboxane A2 3. Science 2002; 296: 539-541
    • (2002) Science , vol.296 , pp. 539-541
    • Cheng, Y.1    Austin, S.C.2    Rocca, B.3
  • 10
    • 53049098236 scopus 로고    scopus 로고
    • Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfu-sion injury in APOE*3Leiden mice are prevented by combined treatment with throm-boxane prostanoid-receptor antagonist S18886 (terutroban)
    • van der Hoorn JW, Jukema JW, Bekkers ME, et al: Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfu-sion injury in APOE*3Leiden mice are prevented by combined treatment with throm-boxane prostanoid-receptor antagonist S18886 (terutroban). Crit Care Med 2008; 36:2576-2582
    • (2008) Crit Care Med , vol.36 , pp. 2576-2582
    • van der Hoorn, J.W.1    Jukema, J.W.2    Bekkers, M.E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.